Loading...
A regulatory role for β-adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina
Diabetic retinopathy is a visually debilitating disease with limited treatment options available. Compound 49b, a β-adrenergic receptor agonist, has been demonstrated to effectively reduce disease pathogenesis associated with diabetic retinopathy. While the exact mechanisms are not fully understood,...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5667888/ https://ncbi.nlm.nih.gov/pubmed/29095817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0185383 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|